13F HOLDINGS REPORT
Bain Capital Life Sciences Investors, LLC
Quarter ended Q3 2024 · Filed November 14, 2024 · Accession 0000950123-24-011417
Total Value
$961.2M
Positions
24
Other Managers
11
Confidential Omitted
No
Holdings (24)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | NUVALENT INC | NUVL | 2,697,267 | $275.9M | 28.71% |
| 2 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 10,473,913 | $173.9M | 18.09% |
| 3 | DISC MEDICINE INC | IRON | 1,795,735 | $88.2M | 9.18% |
| 4 | DIANTHUS THERAPEUTICS INC | DNTH | 3,013,423 | $82.5M | 8.58% |
| 5 | SAVARA INC | SVRA | 14,565,457 | $61.8M | 6.43% |
| 6 | PHARVARIS N V | PHVS | 3,303,381 | $61.2M | 6.36% |
| 7 | ANNEXON INC | ANNX | 8,449,748 | $50.0M | 5.20% |
| 8 | SOLID BIOSCIENCES INC | SLDB | 4,034,582 | $28.1M | 2.93% |
| 9 | TANGO THERAPEUTICS INC | TNGX | 2,712,008 | $20.9M | 2.17% |
| 10 | KYVERNA THERAPEUTICS INC | KYTX | 3,368,370 | $16.5M | 1.71% |
| 11 | MERSANA THERAPEUTICS INC | 59045L106 | 8,663,673 | $16.4M | 1.70% |
| 12 | CABALETTA BIO INC | CABA | 2,760,888 | $13.0M | 1.36% |
| 13 | X4 PHARMACEUTICALS INC | XFOR | 16,915,784 | $11.3M | 1.18% |
| 14 | CENTURY THERAPEUTICS INC | IPSC | 5,410,361 | $9.3M | 0.96% |
| 15 | ATEA PHARMACEUTICALS INC | AVIR | 2,485,638 | $8.3M | 0.87% |
| 16 | CIDARA THERAPEUTICS INC | 171757206 | 703,080 | $7.6M | 0.79% |
| 17 | RAPID MICRO BIOSYSTEMS INC | RPID | 8,434,560 | $7.5M | 0.78% |
| 18 | C4 THERAPEUTICS INC | CCCC | 1,111,910 | $6.3M | 0.66% |
| 19 | SYROS PHARMACEUTICALS INC | 87184Q206 | 2,750,151 | $5.9M | 0.62% |
| 20 | NAUTILUS BIOTECHNOLOGY INC | NAUT | 2,000,000 | $5.7M | 0.59% |
| 21 | MARINUS PHARMACEUTICALS INC | 56854Q200 | 2,693,380 | $4.7M | 0.49% |
| 22 | XILIO THERAPEUTICS INC | XLO | 4,566,817 | $3.6M | 0.37% |
| 23 | INVIVYD INC | IVVD | 1,799,595 | $1.8M | 0.19% |
| 24 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 100,000 | $700,000 | 0.07% |